表紙
市場調查報告書

下一代生物醫藥品製造的全球市場 - 分析與預測:2019-2029年

Global Next-Generation Biomanufacturing Market: Focus on Workflow, Product Type, Medical Applications, End Users, 5 Regional Data, 19 Countries' Data, and Competitive Landscape - Analysis and Forecast, 2019-2029

出版商 BIS Research Inc. 商品編碼 929181
出版日期 內容資訊 英文 265 Pages
商品交期: 最快1-2個工作天內
價格
下一代生物醫藥品製造的全球市場 - 分析與預測:2019-2029年 Global Next-Generation Biomanufacturing Market: Focus on Workflow, Product Type, Medical Applications, End Users, 5 Regional Data, 19 Countries' Data, and Competitive Landscape - Analysis and Forecast, 2019-2029
出版日期: 2020年02月20日內容資訊: 英文 265 Pages
簡介

全球下一代生物醫藥品製造市場規模在2019年∼2029年的預測期間內,預計將以10%的年複合成長率成長。市場規模至2029年預計將達到427億8,000萬美元的規模。

本報告涵括全球下一代生物醫藥品製造市場,提供市場動態,競爭環境,各市場區隔、各地區的市場,競爭情形,及主要企業等相關之詳細分析。

摘要整理

第1章 產品定義

第2章 調查範圍

第3章 調查手法

第4章 全球下一代生物醫藥品製造市場概要

  • 持續進化的醫療保健方案
  • 生物醫藥品製造:簡介
  • 上游及下游工程
  • 生物醫藥品市場成長推動生物醫藥品製造的需求
  • 主要的技術趨勢
  • 生物醫藥品製造的未來:下一代生物醫藥品製造
  • 全球下一代生物醫藥品製造市場規模
  • 市場動態
    • 市場動態的影響分析
  • 前提條件、限制事項

第5章 產業考察

  • 概要
  • 法規方案
  • 專利形勢

第6章 競爭情形

  • 概要
  • 主要策略、發展
  • 市場佔有率分析

第7章 全球下一代生物醫藥品製造市場:各工作流程、產品

  • 概要
  • 上游生物醫藥品製造
  • 下游工程

第8章 全球下一代生物醫藥品製造市場:各醫療用途

  • 概要
  • 疫苗
  • 重組蛋白質
  • 荷爾蒙
  • 其他

第9章 全球下一代生物醫藥品製造市場:各終端用戶

  • 概要
  • 生物醫藥品企業
  • CMO / CDMO
  • 調查機關

第10章 全球下一代生物醫藥品製造市場:各地區

  • 概要
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東、非洲地區

第11章 企業簡介

  • 概要
  • Applikon Biotechnology BV
  • bbi-biotech GmbH
  • Danaher Corporation
  • Eppendorf AG
  • Esco Group of Companies
  • GEA Group Aktiengesellschaft
  • Meissner Filtration Products,Inc.
  • Merck KGaA
  • PBS Biotech, Inc.
  • Pierre Guerin
  • Sartorius AG
  • Shanghai Bailun Biotechnology Co. Ltd.
  • Solaris Biotechnology Srl
  • Thermo Fisher Scientific Inc.
  • ZETA GmbH
目錄
Product Code: BH095A

Global Next-Generation Biomanufacturing Market to Reach $42.78 Billion by 2029, Reports BIS Research

Key Questions Answered in this Report:

  • What is the importance of biomanufacturing in medical field? How the biomanufacturing market is proceeding toward next-generation biomanufacturing?
  • What are the key trends of the global next-generation biomanufacturing market? How is the market evolving and what is its future scope?
  • What are the major drivers, challenges, and opportunities of the global next-generation biomanufacturing market?
  • What are the key developmental strategies implemented by the key players of the global next-generation biomanufacturing to sustain the competition of the market? What is the percentage share of each of the key players in different key developmental strategies?
  • What is the regulatory scenario of the global next-generation biomanufacturing market? What are the initiatives implemented by different governmental bodies and guidelines put forward to regulate the commercialization of next-generation biomanufacturing products?
  • What was the market size of the global next-generation biomanufacturing market in 2018 and what is the market size anticipated to be in 2029? What is the expected growth rate of the global next-generation biomanufacturing market during the period between 2019 and 2029?
  • What are the different next-generation biomanufacturing products used in medical field? Which product type dominated the market in 2018 and why? Which product type is expected to witness highest growth rate and to dominate in the market in 2029?
  • What are the different medical application areas of the global next-generation biomanufacturing market? Which application type dominated the market in 2018 and is expected to dominate in 2029?
  • What are the different end users associated with next-generation biomanufacturing? What was the contribution of each user type in the global next-generation biomanufacturing market in 2018 and what is it expected to be in 2029?
  • What were the market values of the leading segments and sub-segments of the global next-generation biomanufacturing market in 2018 and what are the values expected to be in 2019? What are the different macro and micro factors influencing the growth of the market?
  • Which region is expected to contribute the highest sales in the global next-generation biomanufacturing market during the period between 2018 and 2029? Which region and country carries the potential for the significant expansion of key companies for different next-generation biomanufacturing products? What are the leading countries of different regions that contribute significantly toward the growth of the next-generation biomanufacturing market?
  • What are the key players of the global next-generation biomanufacturing market and what is their role in the market?

Overview on the Global Next-Generation Biomanufacturing Market

The rapid maturation of the biopharmaceutical sector denotes the increasing importance of biomanufacturing as the most basic procedure for the development and manufacture of biologic-based products. With increasing commercialization of biopharmaceuticals and addition of more products in the development pipeline, the biopharmaceutical companies are looking forward to adopting novel biomanufacturing strategies with increased focus on balancing innovation in process design, performance, and efficiency with speed and cost. The need for advanced biomanufacturing practices in order to meet the demand of growing patient population has paved the way for the development of next-generation biomanufacturing products. Next-generation biomanufacturing products are designed to provide seamless services that are superior in terms of both quality and efficiency as compared to first generation products. Increased funding from private investors and the government for the development of next-generation biomanufacturing facilities promoting rapid technological advancement in biomanufacturing products is one of the most prominent factors driving the growth of next-generation biomanufacturing market. One of the major trends of the next-generation biomanufacturing market is the shifting focus toward the adoption of single-use products, such as single-use bioreactors and single-use biocontainers. This is mainly attributed to the huge number of benefits associated with single-use products, with regard to cost savings, reduced risk of product contamination, and increased flexibility in multi-product facilities. With more companies entering the next-generation biomanufacturing market through product innovations, several novel next-generation biomanufacturing products are expected to come up, actively driving the growth of the market in the upcoming years.

Global Next-Generation Biomanufacturing Market Forecast, 2019-2029

The Global Next-Generation Biomanufacturing Market Report by BIS Research projects the market to grow at a significant CAGR of 10% during the forecast period, 2019-2029.

Expert Quote

"The leading contributors in the global next-generation biomanufacturing market predominantly prefer partnerships and alliances to sustain the market competition and strengthen their business position. Most of the market leaders are collaborating with technology-based startups to gain their expertise in the technology."

Scope of the Global Next-Generation Biomanufacturing Market

The report constitutes of an in-depth study of the global next-generation biomanufacturing market, including a thorough analysis of the types of products. The study also presents a detailed analysis of the market dynamics and the estimation of the market size over the forecast period 2019-2029. The scope of this report is focused on the different products, workflow, application areas, end users associated with global next-generation biomanufacturing market, as well as the country-wise analysis.

The purpose of the study is to gain a holistic view of the global next-generation biomanufacturing market in terms of various factors influencing it, including regulatory reforms and technological advancements. The market has been segmented on the basis of 'product type', 'workflow', 'medical application', 'end-user', and 'region'. The scope of this report is centered upon conducting a detailed study of the products allied with the global next-generation biomanufacturing market. In addition, the study also includes exhaustive information on the unmet needs, new products, competitive landscape, market share of leading manufacturers, growth potential of each product, workflow, application, end-user, and region, as well as other vital information with respect to the global next-generation biomanufacturing market.

Market Segmentation

By Workflow and Product

  • Continuous Upstream Biomanufacturing
    • Bioreactors/Fermenters
    • Cell Culture Products
    • Filtration Systems
    • Bags & Containers
    • Mixing System
    • Sterilizers
    • Biosafety Cabinets
    • Incubators
    • Other Instruments and Accessories
  • Single-Use Upstream Biomanufacturing
    • Single-Use Bioreactors
    • Single-Use Bags and Containers
    • Single-Use Tubing and Connectors
    • Single-Use Mixing Systems
    • Single-Use Sensors and Probes
  • Downstream Biomanufacturing
    • Chromatography Systems
    • Filtration Systems
    • Membrane Absorbers
    • Instruments and Accessories
    • Single-Use Equipment and Accessories

By Medical Application

  • Monoclonal Antibodies
  • Hormones
  • Vaccines
  • Recombinant Proteins
  • Others

By End User

  • Commercial Stage
    • Biopharmaceutical Companies
    • CMOs/CDMOs
  • Preclinical and Development Stage
    • Biopharmaceutical Companies
    • CMOs/CDMOs
    • Research Institutions

By Region

  • North America
  • Europe
  • Latin America
  • Middle-East and Africa

Key Companies of the Global Next-Generation Biomanufacturing Industry

The key players contributing to the global next-generation biomanufacturing market are Merck KGaA, Thermo Fisher Scientific Inc., Danaher Corporation, Eppendorf AG, Sartorius AG, GEA Group Aktiengesellschaft, bbi-biotech GmbH, Esco Group of Companies, Pierre Guerin, Solaris Biotechnology Srl., PBS Biotech, Inc., ZETA GmbH, Applikon Biotechnology BV, Meissner Filtration Products, Inc., and Shanghai Bailun Biotechnology Co. Ltd.

Table of Contents

Executive Summary

1 Product Definition

2 Scope of the Work

  • 2.1 Overview: Report Scope
  • 2.2 Segmentation of the Global Next-Generation Biomanufacturing Market
  • 2.3 Assumptions and Limitations
  • 2.4 Key Questions Answered in the Report
  • 2.5 Base Year and Forecast Period

3 Research Methodology

  • 3.1 Overview: Report Methodology

4 Global Next-Generation Biomanufacturing Market Overview

  • 4.1 Ever-Evolving Healthcare Scenario
  • 4.2 Biomanufacturing: An Introduction
  • 4.3 Upstream and Downstream Processing
  • 4.4 Biopharmaceutical Market Growth Boosting Demand for Biomanufacturing
  • 4.5 Key Technology Trends
  • 4.6 The Future of Biomanufacturing: Next-Generation Biomanufacturing
  • 4.7 Global Next-Generation Biomanufacturing Market Size
  • 4.8 Market Dynamics
    • 4.8.1 Impact Analysis of Market Dynamics
  • 4.9 Assumptions and Limitations

5 Industry Insights

  • 5.1 Overview
  • 5.2 Regulatory Scenario
  • 5.3 Patent Landscape

6 Competitive Landscape

  • 6.1 Overview
  • 6.2 Key Developments and Strategies
    • 6.2.1 Partnerships and Alliances
    • 6.2.2 Business Expansions
    • 6.2.3 New Offerings
    • 6.2.4 M & A Activities
    • 6.2.5 Others
  • 6.3 Market Share Analysis

7 Global Next-Generation Biomanufacturing Market (by Workflow and Product)

  • 7.1 Overview
  • 7.2 Upstream Biomanufacturing
    • 7.2.1 Continuous Upstream Biomanufacturing Products
      • 7.2.1.1 Bioreactors/Fermenters
      • 7.2.1.2 Bags and Containers
      • 7.2.1.3 Cell Culture Products
      • 7.2.1.4 Filtration Systems
      • 7.2.1.5 Mixing Systems
      • 7.2.1.6 Sterilizers
      • 7.2.1.7 Biosafety Cabinets
      • 7.2.1.8 Incubators
      • 7.2.1.9 Other Instruments and Accessories
    • 7.2.2 Single-Use Upstream Biomanufacturing Products
      • 7.2.2.1 Single-Use Bioreactors/Fermenters
      • 7.2.2.2 Single-Use Bags and Containers
      • 7.2.2.3 Single-Use Tubing and Connectors
      • 7.2.2.4 Single-Use Mixing Systems
      • 7.2.2.5 Single-Use Sensors and Probes
  • 7.3 Downstream Processing
    • 7.3.1 Downstream Biomanufacturing Products
      • 7.3.1.1 Chromatography Systems
      • 7.3.1.2 Filtration Systems
      • 7.3.1.3 Membrane Adsorbers
      • 7.3.1.4 Instruments and Accessories
      • 7.3.1.5 Single-Use Equipment and Accessories

8 Global Next-Generation Biomanufacturing Market (by Medical Application)

  • 8.1 Overview
  • 8.2 Monoclonal Antibodies
  • 8.3 Vaccines
  • 8.4 Recombinant Proteins
  • 8.5 Hormones
  • 8.6 Others

9 Global Next-Generation Biomanufacturing Market (by End User)

  • 9.1 Overview
  • 9.2 Biopharmaceutical Companies
  • 9.3 CMOs/CDMOs
  • 9.4 Research Institutions

10 Global Next-Generation Biomanufacturing Market (by Region)

  • 10.1 Overview
  • 10.2 North America
    • 10.2.1 Overview
    • 10.2.2 U.S.
    • 10.2.3 Canada
  • 10.3 Europe
    • 10.3.1 Overview
    • 10.3.2 Germany
    • 10.3.3 France
    • 10.3.4 U.K.
    • 10.3.5 Italy
    • 10.3.6 Spain
    • 10.3.7 Ireland
    • 10.3.8 Switzerland
    • 10.3.9 Russia
    • 10.3.10 Rest-of-Europe
  • 10.4 Asia-Pacific
    • 10.4.1 Overview
    • 10.4.2 China
    • 10.4.3 Japan
    • 10.4.4 India
    • 10.4.5 South Korea
    • 10.4.6 Australia
    • 10.4.7 Singapore
    • 10.4.8 Rest-of-Asia-Pacific
  • 10.5 Latin America
  • 10.6 Middle East & Africa

11 Company Profiles

  • 11.1 Overview
  • 11.2 Applikon Biotechnology BV
    • 11.2.1 Company Overview
    • 11.2.2 Role of Applikon Biotechnology BV in the Global Next-Generation Biomanufacturing Market
    • 11.2.3 SWOT Analysis
  • 11.3 bbi-biotech GmbH
    • 11.3.1 Company Overview
    • 11.3.2 Role of bbi-biotech GmbH in the Global Next-Generation Biomanufacturing Market
    • 11.3.3 SWOT Analysis
  • 11.4 Danaher Corporation
    • 11.4.1 Company Overview
    • 11.4.2 Role of Danaher Corporation in the Global Next-Generation Biomanufacturing Market
    • 11.4.3 Financials
    • 11.4.4 SWOT Analysis
  • 11.5 Eppendorf AG
    • 11.5.1 Company Overview
    • 11.5.2 Role of Eppendorf AG in the Global Next-Generation Biomanufacturing Market
    • 11.5.3 Financials
    • 11.5.4 SWOT Analysis
  • 11.6 Esco Group of Companies
    • 11.6.1 Company Overview
    • 11.6.2 Role of Esco Group of Companies in the Global Next-Generation Biomanufacturing Market
    • 11.6.3 SWOT Analysis
  • 11.7 GEA Group Aktiengesellschaft
    • 11.7.1 Company Overview
    • 11.7.2 Role of GEA Group Aktiengesellschaft in the Global Next-Generation Biomanufacturing Market
    • 11.7.3 Financials
    • 11.7.4 SWOT Analysis
  • 11.8 Meissner Filtration Products, Inc.
    • 11.8.1 Company Overview
    • 11.8.2 Role of Meissner Filtration Products, Inc. in the Global Next-Generation Biomanufacturing Market
    • 11.8.3 SWOT Analysis
  • 11.9 Merck KGaA
    • 11.9.1 Company Overview
    • 11.9.2 Role of Merck KGaA in the Global Next-Generation Biomanufacturing Market
    • 11.9.3 Financials
    • 11.9.4 SWOT Analysis
  • 11.10 PBS Biotech, Inc.
    • 11.10.1 Company Overview
    • 11.10.2 Role of PBS Biotech, Inc. in the Global Next-Generation Biomanufacturing Market
    • 11.10.3 SWOT Analysis
  • 11.11 Pierre Guerin
    • 11.11.1 Company Overview
    • 11.11.2 Role of Pierre Guerin in the Global Next-Generation Biomanufacturing Market
    • 11.11.3 SWOT Analysis
  • 11.12 Sartorius AG
    • 11.12.1 Company Overview
    • 11.12.2 Role of Sartorius AG in the Global Next-Generation Biomanufacturing Market
    • 11.12.3 Financials
    • 11.12.4 SWOT Analysis
  • 11.13 Shanghai Bailun Biotechnology Co. Ltd.
    • 11.13.1 Company Overview
    • 11.13.2 Role of Shanghai Bailun Biotechnology Co. Ltd. In the Global Next-Generation Biomanufacturing Market
    • 11.13.3 SWOT Analysis
  • 11.14 Solaris Biotechnology Srl.
    • 11.14.1 Company Overview
    • 11.14.2 Role of Solaris Biotechnology Srl. In the Global Next-Generation Biomanufacturing Market
    • 11.14.3 SWOT Analysis
  • 11.15 Thermo Fisher Scientific Inc.
    • 11.15.1 Company Overview
    • 11.15.2 Role of Thermo Fisher Scientific Inc. in the Global Next-Generation Biomanufacturing Market
    • 11.15.3 Financials
    • 11.15.4 SWOT Analysis
  • 11.16 ZETA GmbH
    • 11.16.1 Company Overview
    • 11.16.2 Role of ZETA GmbH in the Global Next-Generation Biomanufacturing Market
    • 11.16.3 SWOT Analysis

List of Tables

  • Table 1: Leading Segments of the Global Next-Generation Biomanufacturing Market, 2018 and 2029
  • Table 4.1: Impact Analysis of Market Drivers and Restraints
  • Table 5.1: Global Regulatory Scenario
  • Table 5.2: Patents Granted between January 2018 and December 2019
  • Table 10.1: Examples of Biomanufacturers in the U.S. and their Product Offerings

List of Figures

  • Figure 1: Global Next-Generation Biomanufacturing Market (by Region), 2018-2029
  • Figure 2: Key Players of the Global Next-Generation Biomanufacturing Market
  • Figure 3: Drivers and Restraints of the Global Next-Generation Biomanufacturing Market
  • Figure 4: Share of Key Developments and Strategies, January 2017-December 2019
  • Figure 5: Global Next Generation Biomanufacturing Market (by Workflow), 2018-2029
  • Figure 6: Global Next-Generation Biomanufacturing Market Segmentation (by Product)
  • Figure 7: Global Next-Generation Biomanufacturing Market for Upstream Processing, 2018-2029
  • Figure 8: Global Next-Generation Biomanufacturing Market Share (by Product), 2018-2029
  • Figure 9: Global Next Generation Biomanufacturing Market (by Medical Application), 2018-2029
  • Figure 10: Global Next Generation Biomanufacturing Market (Commercial Stage, and Preclinical and Development Stage End-User), 2018-2029
  • Figure 2.1: Global Next-Generation Biomanufacturing Market Segmentation
  • Figure 3.1: Global Next-Generation Biomanufacturing Market Research Methodology
  • Figure 3.2: Primary Research
  • Figure 3.3: Secondary Research
  • Figure 3.4: Data Triangulation
  • Figure 3.5: Bottom-up Approach (Segment-wise Analysis)
  • Figure 3.6: Top-Down Approach (Segment-wise Analysis)
  • Figure 3.7: Assumptions and Limitations
  • Figure 4.1: Steps Involved in Bioprocessing
  • Figure 4.2: Key Facts Demonstrating Rapid Biopharmaceutical Sector Growth
  • Figure 4.3: Global Next-Generation Biomanufacturing Market, 2018-2029
  • Figure 4.4: Global Next-Generation Biomanufacturing Market Segmentation
  • Figure 4.5: Drivers and Challenges of the Global Next-generation Biomanufacturing Market
  • Figure 5.1: Workflow Associated with Biomanufacturing
  • Figure 6.1: Competitive Landscape (January 2017 - December 2019)
  • Figure 6.2: Share of Key Developments and Strategies, January 2017-December 2019
  • Figure 6.3: Partnerships and Alliances (by Company), January 2017 and December 2019
  • Figure 6.4: Business Expansions (by Company), January 2017 and December 2019
  • Figure 6.5: New Offerings (by Company), January 2017 and December 2019
  • Figure 6.6: M & A Activities (by Company), January 2017 and December 2019
  • Figure 6.7: Market Share Analysis of Global Next-Generation Biomanufacturing Market, 2018
  • Figure 7.1: Workflow of Upstream and Downstream Biomanufacturing
  • Figure 7.2: Global Next Generation Biomanufacturing Market (by Workflow), 2018-2029
  • Figure 7.3: Global Next-Generation Biomanufacturing Market Segmentation (by Product)
  • Figure 7.4: Global Next Generation Biomanufacturing Market (by Upstream Processing), 2018-2029
  • Figure 7.5: Global Next Generation Biomanufacturing Market for Continuous Upstream Biomanufacturing Products, 2018-2029
  • Figure 7.6: Global Next Generation Biomanufacturing Market for Bioreactors/Fermentors, 2018-2029
  • Figure 7.7: Global Next Generation Biomanufacturing Market for Bags and Containers, 2018-2029
  • Figure 7.8: Global Next Generation Biomanufacturing Market for Cell Culture Products, 2018-2029
  • Figure 7.9: Global Next Generation Biomanufacturing Market for Filtration Systems, 2018-2029
  • Figure 7.10: Global Next Generation Biomanufacturing Market for Mixing Systems, 2018-2029
  • Figure 7.11: Global Next Generation Biomanufacturing Market for Sterilizers, 2018-2029
  • Figure 7.12: Global Next Generation Biomanufacturing Market for Biosafety Cabinets, 2018-2029
  • Figure 7.13: Global Next Generation Biomanufacturing Market for Incubators, 2018-2029
  • Figure 7.14: Global Next Generation Biomanufacturing Market for Other Instruments and Accessories, 2018-2029
  • Figure 7.15: Global Next Generation Biomanufacturing Market for Single-Use Upstream Biomanufacturing Products, 2018-2029
  • Figure 7.16: Global Next Generation Biomanufacturing Market for Single-Use Bioreactors/Fermentors, 2018-2029
  • Figure 7.17: Global Next Generation Biomanufacturing Market for Single-Use Bags and Containers, 2018-2029
  • Figure 7.18: Global Next Generation Biomanufacturing Market for Single-Use Tubing and Connectors, 2018-2029
  • Figure 7.19: Global Next Generation Biomanufacturing Market for Single-Use Mixing Systems, 2018-2029
  • Figure 7.20: Global Next Generation Biomanufacturing Market for Single-Use Sensors and Probes, 2018-2029
  • Figure 7.21: Global Next Generation Biomanufacturing Market for Downstream Processing, 2018-2029
  • Figure 7.22: Global Next Generation Biomanufacturing Market (by Downstream Biomanufacturing Product), 2018-2029
  • Figure 7.23: Global Next Generation Biomanufacturing Market for Chromatography Systems, 2018-2029
  • Figure 7.24: Global Next Generation Biomanufacturing Market for Filtration Systems, 2018-2029
  • Figure 7.25: Global Next Generation Biomanufacturing Market (by Filtration System), 2018-2029
  • Figure 7.26: Global Next Generation Biomanufacturing Market for Membrane Adsorbers, 2018-2029
  • Figure 7.27: Global Next Generation Biomanufacturing Market for Instruments and Accessories, 2018-2029
  • Figure 7.28: Global Next Generation Biomanufacturing Market for Single-Use Equipment and Accessories, 2018-2029
  • Figure 8.1: Global Next-Generation Biomanufacturing Market Segmentation (by Medical Application)
  • Figure 8.2: Global Next Generation Biomanufacturing Market (by Medical Application), 2018-2029
  • Figure 8.3: Global Next Generation Biomanufacturing Market for Monoclonal Antibodies, 2018-2029
  • Figure 8.4: Global Next Generation Biomanufacturing Market for Vaccines, 2018-2029
  • Figure 8.5: Global Next-Generation Biomanufacturing Market for Recombinant Proteins, 2018-2029
  • Figure 8.6: Global Next Generation Biomanufacturing Market for Hormones, 2018-2029
  • Figure 8.7: Global Next Generation Biomanufacturing Market for Other Applications, 2018-2029
  • Figure 9.1: Global Next-Generation Biomanufacturing Market Segmentation (by End User)
  • Figure 9.2: Global Next Generation Biomanufacturing Market (by End User), 2018-2029
  • Figure 9.3: Global Next Generation Biomanufacturing Market for Commercial Stage and Preclinical and Development Stage End Users, 2018-2029
  • Figure 9.4: Global Next Generation Biomanufacturing Market for Biopharmaceutical Companies, 2018-2029
  • Figure 9.5: Global Next-Generation Biomanufacturing Market for CMOs/CDMOs, 2018-2029
  • Figure 9.6: Global Next Generation Biomanufacturing Market for Research Institutions, 2018-2029
  • Figure 10.1: Global Next-Generation Biomanufacturing Market (by Region), 2018-2029
  • Figure 10.2: North America: Next-Generation Biomanufacturing Market, 2018-2029
  • Figure 10.3: North America: Market Dynamics
  • Figure 10.4: North America: Next-Generation Biomanufacturing Market (by Country), 2018 and 2029
  • Figure 10.5: U.S.: Next-Generation Biomanufacturing Market, 2018-2029
  • Figure 10.6: Canada: Next-Generation Biomanufacturing Market, 2018-2029
  • Figure 10.7: Europe: Next-Generation Biomanufacturing Market, 2018-2029
  • Figure 10.8: Europe: Market Dynamics
  • Figure 10.9: Europe: Next-Generation Biomanufacturing Market (by Country), 2018 and 2029
  • Figure 10.10: Germany: Next-Generation Biomanufacturing Market, 2018-2029
  • Figure 10.11: France: Next-Generation Biomanufacturing Market, 2018-2029
  • Figure 10.12: U.K.: Next-Generation Biomanufacturing Market, 2018-2029
  • Figure 10.13: Italy: Next-Generation Biomanufacturing Market, 2018-2029
  • Figure 10.14: Spain: Next-Generation Biomanufacturing Market, 2018-2029
  • Figure 10.15: Ireland: Next-Generation Biomanufacturing Market, 2018-2029
  • Figure 10.16: Switzerland: Next-Generation Biomanufacturing Market, 2018-2029
  • Figure 10.17: Russia: Next-Generation Biomanufacturing Market, 2018-2029
  • Figure 10.18: Rest-of-Europe: Next-Generation Biomanufacturing Market, 2018-2029
  • Figure 10.19: Asia-Pacific: Next-Generation Biomanufacturing Market, 2018-2029
  • Figure 10.20: Asia-Pacific: Market Dynamics
  • Figure 10.21: Asia-Pacific: Next-Generation Biomanufacturing Market (by Country), 2018-2029
  • Figure 10.22: China: Next-Generation Biomanufacturing Market, 2018-2029
  • Figure 10.23: Japan: Next-Generation Biomanufacturing Market, 2018-2029
  • Figure 10.24: India: Next-Generation Biomanufacturing Market, 2018-2029
  • Figure 10.25: South Korea: Next-Generation Biomanufacturing Market, 2018-2029
  • Figure 10.26: Australia: Next-Generation Biomanufacturing Market, 2018-2029
  • Figure 10.27: Singapore: Next-Generation Biomanufacturing Market, 2018-2029
  • Figure 10.28: Rest-of-Asia-Pacific: Next-Generation Biomanufacturing Market, 2018-2029
  • Figure 10.29: Latin America: Next-Generation Biomanufacturing Market, 2018-2029
  • Figure 10.30: Latin America: Next-Generation Biomanufacturing Market (by Country), 2018-2029
  • Figure 10.31: Middle East and Africa: Next-Generation Biomanufacturing Market, 2018-2029
  • Figure 11.1: Shares of Key Company Profiles
  • Figure 11.2: Applikon Biotechnology BV: Product Portfolio for Global Next-Generation Biomanufacturing Market
  • Figure 11.3: Applikon Biotechnology BV: SWOT Analysis
  • Figure 11.4: bbi-biotech GmbH: Product Portfolio for Global Next-Generation Biomanufacturing Market
  • Figure 11.5: bbi-biotech GmbH: SWOT Analysis
  • Figure 11.6: Danaher Corporation: Product Portfolio for Global Next-Generation Biomanufacturing Market
  • Figure 11.7: Danaher Corporation: Overall Financials, 2016-2018
  • Figure 11.8: Danaher Corporation: Revenue (by Business Segment), 2016-2018
  • Figure 11.9: Danaher Corporation: Revenue (by Region), 2016-2018
  • Figure 11.10: Danaher Corporation: R&D Expenditure (2016-2018)
  • Figure 11.11: Danaher Corporation: SWOT Analysis
  • Figure 11.12: Eppendorf AG: Product Portfolio for Global Next-Generation Biomanufacturing Market
  • Figure 11.13: Eppendorf AG: Overall Financials, 2016-2018
  • Figure 11.14: Eppendorf AG: Revenue (by Region), 2016-2018
  • Figure 11.15: Eppendorf AG: R&D Expenditure (2016-2018)
  • Figure 11.16: Eppendorf AG: SWOT Analysis
  • Figure 11.17: Esco Group of Companies: Product Portfolio for Global Next-Generation Biomanufacturing Market
  • Figure 11.18: Esco Group of Companies: SWOT Analysis
  • Figure 11.19: GEA Group Aktiengesellschaft: Product Portfolio for Global Next-Generation Biomanufacturing Market
  • Figure 11.20: GEA Group Aktiengesellschaft: Overall Financials, 2016-2018
  • Figure 11.21: GEA Group Aktiengesellschaft: Revenue (by Business Segment), 2016-2018
  • Figure 11.22: GEA Group Aktiengesellschaft: Revenue (by Region), 2016-2018
  • Figure 11.23: GEA Group Aktiengesellschaft: R&D Expenditure (2016-2018)
  • Figure 11.24: GEA Group Aktiengesellschaft: SWOT Analysis
  • Figure 11.25: Meissner Filtration Products, Inc.: Product Portfolio for Global Next-Generation Biomanufacturing Market
  • Figure 11.26: Meissner Filtration Products, Inc.: SWOT Analysis
  • Figure 11.27: Merck KGaA: Product Portfolio for Global Next-Generation Biomanufacturing Market
  • Figure 11.28: Merck KGaA: Overall Financials, 2016-2018
  • Figure 11.29: Merck KGaA: Revenue (by Segment), 2016-2018
  • Figure 11.30: Merck KGaA: Revenue (by Region), 2016-2018
  • Figure 11.31: Merck KGaA: R&D Expenditure (2016-2018)
  • Figure 11.32: Merck KGaA: SWOT Analysis
  • Figure 11.33: PBS Biotech, Inc.: Product Portfolio for Global Next-Generation Biomanufacturing Market
  • Figure 11.34: PBS Biotech, Inc.: SWOT Analysis
  • Figure 11.35: Pierre Guerin: Product Portfolio for Global Next-Generation Biomanufacturing Market
  • Figure 11.36: Pierre Guerin: SWOT Analysis
  • Figure 11.37: Sartorius AG: Product Portfolio for Global Next-Generation Biomanufacturing Market
  • Figure 11.38: Sartorius AG: Overall Financials, 2016-2018
  • Figure 11.39: Sartorius AG: Revenue (by Business Segment), 2016-2018
  • Figure 11.40: Sartorius AG: Revenue (by Region), 2016-2018
  • Figure 11.41: Sartorius AG: R&D Expenditure (2016-2018)
  • Figure 11.42: Sartorius AG: SWOT Analysis
  • Figure 11.43: Shanghai Bailun Biotechnology Co. Ltd.: Product Portfolio for Global Next-Generation Biomanufacturing Market
  • Figure 11.44: Shanghai Bailun Biotechnology Co. Ltd.: SWOT Analysis
  • Figure 11.45: Solaris Biotechnology Srl.: Product Portfolio for Global Next-Generation Biomanufacturing Market
  • Figure 11.46: Solaris Biotechnology Srl.: SWOT Analysis
  • Figure 11.47: Thermo Fisher Scientific Inc.: Product Portfolio for Global Next-Generation Biomanufacturing Market
  • Figure 11.48: Thermo Fisher Scientific Inc.: Overall Financials, 2016-2018
  • Figure 11.49: Thermo Fisher Scientific Inc.: Revenue (by Business Segment), 2016-2018
  • Figure 11.50: Thermo Fisher Scientific Inc.: Revenue (by Region), 2016-2018
  • Figure 11.51: Thermo Fisher Scientific Inc.: R&D Expenditure (2016-2018)
  • Figure 11.52: Thermo Fisher Scientific Inc.: SWOT Analysis
  • Figure 11.53: ZETA GmbH: Product Portfolio for Global Next-Generation Biomanufacturing Market
  • Figure 11.54: ZETA GmbH: SWOT Analysis